Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Optimising secondary prevention in the acute period following a TIA of ischaemic origin.

Heron N.

BMJ Open Sport Exerc Med. 2017 Jan 6;2(1):e000161. doi: 10.1136/bmjsem-2016-000161. eCollection 2016. Review.

2.

Understanding Neurologic Complications Following TAVR.

Mohammed Imran G, Alexandra L.

Interv Cardiol. 2018 Jan;13(1):27-32. doi: 10.15420/icr.2017:25:1.

3.

Implementation of a Rapid, Protocol-based TIA Management Pathway.

Jarhult SJ, Howell ML, Barnaure-Nachbar I, Chang Y, White BA, Amatangelo M, Brown DF, Singhal AB, Schwamm LH, Silverman SB, Goldstein JN.

West J Emerg Med. 2018 Mar;19(2):216-223. doi: 10.5811/westjem.2017.9.35341. Epub 2018 Feb 8.

4.

Autonomic Nervous System and Stress to Predict Secondary Ischemic Events after Transient Ischemic Attack or Minor Stroke: Possible Implications of Heart Rate Variability.

Guan L, Collet JP, Mazowita G, Claydon VE.

Front Neurol. 2018 Mar 5;9:90. doi: 10.3389/fneur.2018.00090. eCollection 2018.

5.

Eyes and stroke: the visual aspects of cerebrovascular disease.

Pula JH, Yuen CA.

Stroke Vasc Neurol. 2017 Jul 6;2(4):210-220. doi: 10.1136/svn-2017-000079. eCollection 2017 Dec. Review.

6.

Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.

Yoshida Y, Wang H, Hiwasa T, Machida T, Kobayashi E, Mine S, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Takizawa H, Kashiwado K, Kamitsukasa I, Shin H, Wada T, Aotsuka A, Nishi E, Ohno M, Takemoto M, Yokote K, Takahashi S, Matsushima J, Zhang XM, Takiguchi M, Iwadate Y.

Oncotarget. 2017 Dec 24;9(10):8836-8848. doi: 10.18632/oncotarget.23653. eCollection 2018 Feb 6.

7.

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.

Wang H, Zhang XM, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kimura R, Mine S, Kamitsukasa I, Wada T, Aotsuka A, Yoshida Y, Kobayashi E, Matsutani T, Iwadate Y, Sugimoto K, Mori M, Uzawa A, Muto M, Kuwabara S, Takemoto M, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Machida T, Takizawa H, Kashiwado K, Shimada H, Ito M, Goto KI, Iwase K, Ashino H, Taira A, Arita E, Takiguchi M, Hiwasa T.

Oncotarget. 2017 Dec 31;9(5):5600-5613. doi: 10.18632/oncotarget.23789. eCollection 2018 Jan 19.

8.

Diagnosing Stroke in Acute Dizziness and Vertigo: Pitfalls and Pearls.

Saber Tehrani AS, Kattah JC, Kerber KA, Gold DR, Zee DS, Urrutia VC, Newman-Toker DE.

Stroke. 2018 Mar;49(3):788-795. doi: 10.1161/STROKEAHA.117.016979. Epub 2018 Feb 19. Review. No abstract available.

PMID:
29459396
9.

Cost-saving innovations for acute ischemic stroke and transient ischemic attack.

Tai WA, Conley J, Kalanithi L.

Neurol Clin Pract. 2014 Oct;4(5):427-434. doi: 10.1212/CPJ.0000000000000081.

10.

Establishing research priorities relating to the long-term impact of TIA and minor stroke through stakeholder-centred consensus.

Turner GM, Backman R, McMullan C, Mathers J, Marshall T, Calvert M.

Res Involv Engagem. 2018 Jan 25;4:2. doi: 10.1186/s40900-018-0089-z. eCollection 2018.

11.

Quality of Care for Veterans With Transient Ischemic Attack and Minor Stroke.

Bravata DM, Myers LJ, Arling G, Miech EJ, Damush T, Sico JJ, Phipps MS, Zillich AJ, Yu Z, Reeves M, Williams LS, Johanning J, Chaturvedi S, Baye F, Ofner S, Austin C, Ferguson J, Graham GD, Rhude R, Kessler CS, Higgins DS Jr, Cheng E.

JAMA Neurol. 2018 Apr 1;75(4):419-427. doi: 10.1001/jamaneurol.2017.4648.

PMID:
29404578
12.

Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer.

Addison D, Lawler PR, Emami H, Janjua SA, Staziaki PV, Hallett TR, Hennessy O, Lee H, Szilveszter B, Lu M, Mousavi N, Nayor MG, Delling FN, Romero JM, Wirth LJ, Chan AW, Hoffmann U, Neilan TG.

J Stroke. 2018 Jan;20(1):71-79. doi: 10.5853/jos.2017.01802. Epub 2018 Jan 31.

13.

Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial.

Choi MH, Lee JS, Lee SE, Lee SJ, Yoon D, Park RW, Hong JM.

Sci Rep. 2018 Jan 24;8(1):1556. doi: 10.1038/s41598-018-19998-4.

14.

Small cortical grey matter lesions show no persistent infarction in transient ischaemic attack? A prospective cohort study.

Havsteen I, Ovesen C, Willer L, Nybing JD, Ægidius K, Marstrand J, Meden P, Rosenbaum S, Folke MN, Christensen H, Christensen A.

BMJ Open. 2018 Jan 21;8(1):e018160. doi: 10.1136/bmjopen-2017-018160.

15.

White Matter Lesions Predict Recurrent Vascular Events in Patients with Transient Ischemic Attacks.

Ren XM, Qiu SW, Liu RY, Wu WB, Xu Y, Zhou H.

Chin Med J (Engl). 2018 Jan 20;131(2):130-136. doi: 10.4103/0366-6999.222341.

16.

ABCD3-I score and the risk of early or 3-month stroke recurrence in tissue- and time-based definitions of TIA and minor stroke.

Mayer L, Ferrari J, Krebs S, Boehme C, Toell T, Matosevic B, Tinchon A, Brainin M, Gattringer T, Sommer P, Thun P, Willeit J, Lang W, Kiechl S, Knoflach M; Austrian Stroke Unit Collaborators.

J Neurol. 2018 Mar;265(3):530-534. doi: 10.1007/s00415-017-8720-8. Epub 2018 Jan 11.

17.

Adjudication of Transient Ischemic Attack and Stroke in the Multi-Ethnic Study of Atherosclerosis.

Longstreth WT Jr, Gasca NC, Gottesman RF, Pearce JB, Sacco RL.

Neuroepidemiology. 2018;50(1-2):23-28. doi: 10.1159/000486174. Epub 2018 Jan 11.

18.

Effect of early hospital readmission and comorbid conditions on subsequent long-term mortality after transient ischemic attack.

Yousufuddin M, Young N, Keenan L, Olson T, Shultz J, Doyle T, Ahmmad E, Arumaithurai K, Takahashi P, Murad MH.

Brain Behav. 2017 Nov 22;7(12):e00865. doi: 10.1002/brb3.865. eCollection 2017 Dec.

19.

Atrial Fibrillation Predictors on Mobile Cardiac Telemetry in Cryptogenic Ischemic Stroke.

Kass-Hout O, Kass-Hout T, Parikh A, Hoskins M, Clements SD Jr, Rangaraju S, Noorian AR, Ayala L, Blanke D, Bamford L, Anderson A, Belagaje S, Yepes M, Frankel M, Nahab F.

Neurohospitalist. 2018 Jan;8(1):7-11. doi: 10.1177/1941874417711761. Epub 2017 Jun 5.

PMID:
29276556
20.

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity.

Tornyos A, Aradi D, Horváth IG, Kónyi A, Magyari B, Pintér T, Vorobcsuk A, Tornyos D, Komócsi A.

PLoS One. 2017 Dec 7;12(12):e0188493. doi: 10.1371/journal.pone.0188493. eCollection 2017.

Supplemental Content

Support Center